A subscription to JoVE is required to view this content. Sign in or start your free trial.
Here, we present protocols to investigate impairment of the neurovascular unit during experimental autoimmune encephalomyelitis in vivo. We specifically address how to determine blood-brain barrier permeability and gelatinase activity involved in leukocyte migration across the glia limitans.Â
The neurovascular unit (NVU) is composed of microvascular endothelial cells forming the blood-brain barrier (BBB), an endothelial basement membrane with embedded pericytes, and the glia limitans composed by the parenchymal basement membrane and astrocytic end-feed embracing the abluminal aspect of central nervous system (CNS) microvessels. In addition to maintaining CNS homeostasis the NVU controls immune cell trafficking into the CNS. During immunosurveillance of the CNS low numbers of activated lymphocytes can cross the endothelial barrier without causing BBB dysfunction or clinical disease. In contrast, during neuroinflammation such as in multiple sclerosis or its animal model experimental autoimmune encephalomyelitis (EAE) a large number of immune cells can cross the BBB and subsequently the glia limitans eventually reaching the CNS parenchyma leading to clinical disease. Immune cell migration into the CNS parenchyma is thus a two-step process that involves a sequential migration across the endothelial and glial barrier of the NVU employing distinct molecular mechanisms. If following their passage across the endothelial barrier, T cells encounter their cognate antigen on perivascular antigen-presenting cells their local reactivation will initiate subsequent mechanisms leading to the focal activation of gelatinases, which will enable the T cells to cross the glial barrier and enter the CNS parenchyma. Thus, assessing both, BBB permeability and MMP activity in spatial correlation to immune cell accumulation in the CNS during EAE allows to specify loss of integrity of the endothelial and glial barriers of the NVU. We here show how to induce EAE in C57BL/6 mice by active immunization and how to subsequently analyze BBB permeability in vivo using a combination of exogenous fluorescent tracers. We further show, how to visualize and localize gelatinase activity in EAE brains by in situ zymogaphy coupled to immunofluorescent stainings of BBB basement membranes and CD45+ invading immune cells.
The central nervous system (CNS) coordinates all body and mental functions in vertebrates, and CNS homeostasis is essential for a proper communication of neurons. CNS homeostasis is warranted by the neurovascular unit (NVU), which protects the CNS from the changing milieu of the blood stream. The NVU is composed of CNS microvascular endothelial cells, which are biochemically unique and establish the blood-brain barrier (BBB) in continuous crosstalk with pericytes, astrocytes, neurons, and extracellular matrix (ECM) components, establishing two distinct basement membranes1. The endothelial basement membrane that ensheathes the abluminal aspect o....
All studies were conducted under the guidelines according to the Swiss legislation on the protection of animals and were approved by the Veterinary Office of the Canton of Bern, Switzerland (permission numbers: BE 31/17 and BE 77/18).
1. Housing of C57BL/6 mice in specific pathogen free (SPF) conditions
Assessment of the clinical course of EAE in C57BL/6 mice should result in a disease curve as depicted in Figure 2A and changes in the mouse body weight as presented in Figure 2B. C57BL/6 mice immunized with MOGaa35-55 usually start to develop disease symptoms around day 10-12 after active immunization (Figure 1A). Typically, immunized mice show a transient drop of body weight the day after the injection of the emulsion and the first.......
Here, we present a protocol to induce and monitor EAE in female C57BL/6 mice. Females are preferentially chosen, and there is a incidence of women : men of 3:1 in MS. To assess the severity of EAE, we made use of a 3-point scoring sheet. EAE severity is generally scored with respect to the severity of motor dysfunctions. Mice with advanced stages of EAE, i.e. exhibiting a score above 2 should be sacrificed to avoid unnecessary suffering of the animals. Thus, it is recommended to score the mice at close intervals e.g. twi.......
We gratefully acknowledge Lydia Sorokin, who has shared her original in situ zymography protocol10 with us.Â
....Name | Company | Catalog Number | Comments |
AMCA anti-rabbit antibody | Jackson ImmunoResearch | 111-156-045 | Store at 4 °C; protect from light |
Anti-CD45 Antibody (30F11) | Pharmingen | 07-1401 | Store at 4 °C |
Anti-Laminin Antibody | DAKO | Z0097 | Store at 4 °C |
Breeding food | e.g. PROVIMI KLIBA SA | 3336 | |
Individually ventilated cages, Blue line Type II or III | e.g. Tecniplast | 1145T, 1285L | |
BSA fraction V | Applichem | A1391 | Store at 4 °C |
Cold gelatine | Sigma-Aldrich | G 9391 | |
Coplin jar + rack | e.g. Carl Roth GmbH + Co. KG | H554.1; H552.1 | |
Cy3 anti-rat antibody | Jackson ImmunoResearch | 111-156-144 | Store at 4 °C; protect from light |
Cover slips 24 x 40 mm # 1 | e.g. Thermo Scientific | 85-0186-00 | |
Dextran Alexa Fluor 488 (10,000 MW) | e.g. Molecular probes | D22910 | Store at -20 °C; protect from light |
Dextran Texas Red (3000 MW) | Invitrogen | D3328 | Store at -20 °C; protect from light |
EnzChek Gelatinase/Collagenase Assay Kit | Thermo Fisher Scientific; EnzCheck | E12055 | Store at -20 °C; protect form light |
Female C57BL/6J mice (8-12 weeks) | e.g. Janvier Labs | Females, 8-12 weeks | |
Freezing box for histology slides | e.g. Carl Roth GmbH + Co. KG | 2285.1 | |
18G x 1½’’ (1.2mm x 40mm) injection needle | e.g. BD, BD Microlance 3 | 304622 | |
27G x ¾’’ – Nr. 20 (0.4mm x 19mm) injection needle | e.g. BD, BD Microlance 3 | 302200 | |
30G x ½’’ (0.3 mm x 13 mm) injection needle | e.g. BD, BD Microlance 3 | 304000 | |
Incomplete Freund’s adjuvant (IFA) | e.g. Santa Cruz Biotechnology | sc-24648 | Store at 4°C |
Maintenance food | e.g. PROVIMI KLIBA SA | 3436 | |
MOGaa35-55 peptide | e.g. GenScript | Store at -80 °C | |
microscope slides (Superfrost Plus ) | Thermo Scientific | J1800AMNZ | |
Mycobacterium tuberculosis H37RA | e.g. BD | 231141 | Store at 4 °C |
NaCl 0.9 % | B. Braun | 3535789 | |
O.C.T. compound (Tissue-Tek ) | Sakura | 4583 | |
Omnican 50 30G x ½’’ | B. Braun | 9151125S | |
Paraformaldehyde | Merck | 30525-89-4 | |
Pertussis toxin | e.g. List biological laboratories, Inc. | 180 | Store at 4 °C |
poly(vinyl alcohole) (Mowiol 4-88) | Sigma-Aldrich | 81381 | |
Protease Inhibitor EDTA free (Roche) | Sigma-Aldrich | 4693132001 | Store at 4 °C |
repelling pen e.g. DAKO Pen | e.g. DAKO | S2002 | |
sealing film e.g. Parafilm M | e.g Sigma-Aldrich | P7793 | |
Silica gel | e.g. Carl Roth GmbH + Co. KG | 9351.1 | |
Stitch scissor | F.S.T | 15012-12 | |
syringe 1 ml | e.g. PRIMO | 62.1002 | |
syringe 10 ml | e.g. CODAN Medical ApS | 2022-05 | |
vaporizer system Univentor 400 | UNO.BV |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved